"First half of 2023 is another solid performance for InterCure, with year-over-year revenue growing 14% to $ million and adjusted EBITDA margin of 14%. I am proud of our team ability to execute ...
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive ...
Collaboration comes amidst reports that the Trump administration is exploring cannabis rescheduling, expected to create unprecedented opportunities in the U.S. for international operators like ...
Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA 1 of NIS 21 million (Approximately 17% of revenues). Alexander Rabinovitch, CEO of InterCure noted: ...
InterCure Ltd. (NASDAQ:INCR) revealed on Friday that it will acquire Botanico Ltd., known as ISHI, in a move designed to strengthen its global cannabis portfolio and deliver entry into premium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback